Variable | Total MoCA score | t | P-value | |||
---|---|---|---|---|---|---|
≥ 26 (n = 41) | < 26 (n = 44) | |||||
Mean ± SD | Mean ± SD | |||||
Age | 32.07 ± 8.11 | 39.57 ± 9.15 | − 3.99 | < 0.001 | ||
 | No | % | No | % | χ2 |  |
Gender | ||||||
 Female | 32 | 78.0 | 37 | 84.1 | 0.51 | 0.476 |
 Male | 9 | 22.0 | 7 | 15.9 | ||
Marital status | ||||||
 Married | 34 | 82.9 | 41 | 93.2 | 2.15 | 0.143 |
 Not married | 7 | 17.1 | 3 | 6.8 | ||
Residence | ||||||
 Rural | 23 | 56.1 | 32 | 72.7 | 2.57 | 0.109 |
 Urban | 18 | 48.2 | 12 | 27.3 | ||
Level of education | ||||||
 Low-to-moderate | 17 | 41.5 | 36 | 81.8 | 14.72 | < 0.001 |
 High | 24 | 58.5 | 8 | 18.2 | ||
Occupation | ||||||
 Skilled | 39 | 95.1 | 38 | 86.4 | 2.20 | 0.334 |
 Employee | 2 | 4.9 | 5 | 11.4 | ||
 Unemployed | 0 | 0.0 | 1 | 2.3 | ||
Hx of psychiatric illnesses | ||||||
 Yes | 2 | 4.9 | 5 | 11.4 | 1.18 | 0.277 |
 No | 39 | 95.1 | 39 | 88.6 | ||
Hx of medical illnesses | ||||||
 Yes | 8 | 19.5 | 11 | 25.0 | 0.37 | 0.544 |
 No | 33 | 80.5 | 33 | 75.0 | ||
COVID-19 symptom severity | ||||||
 Mild | 21 | 51.2 | 19 | 43.2 | 0.55 | 0.458 |
 Moderate-to-severe | 20 | 48.8 | 25 | 56.8 | ||
Medications received during COVID-19 infection | ||||||
 Antibiotics | 36 | 97.3 | 38 | 92.7 | 0.85 | 0.356 |
 Anticoagulants | 22 | 59.5 | 27 | 65.9 | 0.34 | 0.560 |
 Antimalarial | 17 | 45.9 | 20 | 48.8 | 0.06 | 0.802 |
 Iverizine | 28 | 75.7 | 25 | 61.0 | 1.93 | 0.165 |
 Steroids | 21 | 56.8 | 24 | 58.5 | 0.03 | 0.874 |
 | Mean ± SD | Mean ± SD | MWU |  | ||
Home isolation (days) | 9.80 ± 9.08 | 9.70 ± 10.20 | − 0.38 | 0.418 | ||
Hospital isolation (days) | 5.76 ± 8.71 | 7.20 ± 9.38 | − 0.81 | 0.707 | ||
HADS scoring | ||||||
 Depression | 7.22 ± 4.56 | 9.02 ± 3.61 | − 2.00 | 0.045 | ||
 Anxiety | 7.34 ± 4.65 | 9.07 ± 3.61 | − 1.80 | 0.072 |